Key result
Transcatheter aortic valve implantation (TAVI) has emerged as a less invasive alternative for the 30% of aortic valve stenosis patients left untreated due to high surgical risk.
This review provides an overview of the evolution, current state, and future directions of transcatheter aortic valve implantation technologies and patents.
No takes yet. Share an insight, caveat, or question.
May support TAVI consideration in high-risk aortic stenosis; leaves open patent-driven device refinements for researchers.
Stathogiannis et al. (2012) conducted a review in Aortic valve stenosis. Transcatheter aortic valve implantation (TAVI) was evaluated. Transcatheter aortic valve implantation (TAVI) has emerged as a less invasive alternative for the 30% of aortic valve stenosis patients left untreated due to high surgical risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: